Literature DB >> 3334969

Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.

J L Rutgers1, R E Scully.   

Abstract

Ovarian mucinous cystadenomas of borderline malignancy that contain foci of intestinal differentiation are well recognized. Borderline tumors lined by mucinous epithelium of endocervical type and characterized by papillae architecturally similar to those of serous borderline tumors, however, have not been described in the literature. We have studied 30 tumors of this type. The patients averaged 34 years of age. Forty percent of the tumors were synchronously bilateral and 30% were associated with endometriosis. Four tumors were complicated by peritoneal implants, one by both peritoneal implants and lymph node metastasis and one by lymph node metastasis alone. No patient had pseudomyxoma peritonei. Follow-up information was available on all the patients for a mean interval of 3.7 years. In two cases tumors developed in the conserved contralateral ovary; no deaths occurred. These tumors have important clinical and pathologic differences from mucinous borderline tumors with intestinal differentiation, but have many similarities to mixed-epithelial borderline tumors of Mullerian type.

Entities:  

Mesh:

Year:  1988        PMID: 3334969     DOI: 10.1002/1097-0142(19880115)61:2<340::aid-cncr2820610225>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

1.  Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.

Authors:  Taira Hada; Morikazu Miyamoto; Hiroki Ishibashi; Haruka Kawauchi; Hiroaki Soyama; Hiroko Matsuura; Takahiro Sakamoto; Soichiro Kakimoto; Tadashi Aoyama; Hideki Iwahashi; Rie Suzuki; Hitoshi Tsuda; Masashi Takano
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Expression of a homeobox gene (SIX5) in borderline ovarian tumours.

Authors:  C Winchester; S Robertson; T MacLeod; K Johnson; M Thomas
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

3.  Adhering to the 2014 WHO terminology on borderline ovarian tumors.

Authors:  Jaime Prat
Journal:  Virchows Arch       Date:  2017-02       Impact factor: 4.064

Review 4.  Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.

Authors:  Daichi Maeda; Ie-Ming Shih
Journal:  Adv Anat Pathol       Date:  2013-01       Impact factor: 3.875

Review 5.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

6.  Intestinal differentiation in ovarian mucinous tumours.

Authors:  N J Ball; D I Robertson; M A Duggan; D D Snider
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 7.  Seromucinous Tumors of the Ovary. What's in a Name?

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2016-01       Impact factor: 2.762

Review 8.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

9.  MR imaging findings of extraovarian endocervical mucinous borderline tumors arising from pelvic endometriosis.

Authors:  Dong Myung Yeo; Sung Eun Rha; Jae Young Byun; Ahwon Lee; Mee-Ran Kim
Journal:  Korean J Radiol       Date:  2013-11-05       Impact factor: 3.500

10.  Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.

Authors:  Sang Kyum Kim; Si Young Song; Sunghoon Kim; Nam Hoon Cho; Ga Won Yim; Sang Wun Kim; Young Tae Kim; Eun Ji Nam
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.